{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-028900","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.072568+00:00","generated_at":"2026-06-13T21:45:53.971978+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"MiNK Therapeutics stockholders elect Garo Armen and Barbara Ryan as Class II directors, ratify KPMG as auditor","bullets":["Garo Armen received 29,157,446 for and 282,326 withheld; Barbara Ryan 29,193,530 for and 246,242 withheld.","KPMG LLP ratified as independent auditor for FY2023 with 30,644,494 for, 5,764 against, 110,413 abstentions.","Quorum of 30,760,671 shares (89.6% of outstanding) present at June 13, 2023 Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-028900","json":"https://secwatch.observer/filing/0000950170-23-028900.json","markdown":"https://secwatch.observer/filing/0000950170-23-028900.md","text":"https://secwatch.observer/filing/0000950170-23-028900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/0000950170-23-028900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/inkt-20230613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T21:45:53.971978+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b54c9e49ff2ba4ab6bd5d4440c3b7d3532780e57","claim":"MiNK Therapeutics, Inc. shareholders approved Election of Garo Armen and Barbara Ryan as Class II directors at the 2023-06-13 meeting.","evidence_excerpt":"Class II Director Nominees For Against Withheld Broker Non-Votes Garo Armen 29,157,446 0 282,326 1,320,899 Barbara Ryan 29,193,530 0 246,242 1,320,899","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/0000950170-23-028900-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-13"}],"fact_type":"shareholder_vote"},{"claim_id":"ea35895342821e96a9510f24eb2079d2a003ecb5","claim":"MiNK Therapeutics, Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-13 meeting.","evidence_excerpt":"The votes cast at the Annual Meeting were as follows: For Against Withheld Broker Non-Votes 30,644,494 5,764 110,413 NA","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/0000950170-23-028900-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-13"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}